EUVIMEDEUVIMED entdecken
Crossref

Enhanced Siglec-8 and HLA-DR and reduced CRTH2 surface expression highlight a distinct phenotypic signature of circulating eosinophils in atopic dermatitis

Frédéric Dezoteux iD, Pierre Marcant iD, Arnaud Dendooven iD, Émeline Delaunay, Stéphane Esnault iD, Jacques Trauet, Guillaume Lefèvre iD, Delphine Staumont-Sallé iD

Journal of Leukocyte Biology · 2025

DOI: 10.1093/jleuko/qiaf023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Frédéric Dezoteux und 7 weiteren Autor:innen. Beteiligte Einrichtung: CHU Lille, Univ. Lille, Service de Dermatologie, Rue Michel Polonowski, F-59000 Lille, France. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Eosinophils, Antigens, CD, HLA-DR Antigens. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: French Society of Dermatology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis and other type 2 immune response diseases are often linked to elevated eosinophil levels in the blood. Although the role of eosinophils in atopic dermatitis pathophysiology is suspected, it remains unclear. The development of new treatments targeting the type 2 response, particularly cytokines involved in eosinophil activation and chemotaxis, makes it necessary to identify potential eosinophil profiles in atopic dermatitis that may respond to these treatments. A prospective study was conducted comparing blood eosinophil phenotypes in patients with moderate to severe atopic dermatitis (n = 19) without recent systemic treatment to healthy individuals (n = 19). The primary outcome was the membranous phenotypic signature of eosinophils, assessed by flow cytometry. Most patients with atopic dermatitis (84%) had early onset in childhood, a severe disease (mean SCORing Atopic Dermatitis of 57.5), and elevated blood eosinophil counts (310 per µL in atopic dermatitis vs 120 in healthy individuals, P < 0.0001). Patients with atopic dermatitis exhibited lower CRTH2 on eosinophils but higher levels of human leukocyte antigen–DR isotype and Siglec-8 compared to healthy individuals. Other surface proteins showed no significant differences. Clustering analysis confirmed increased Siglec-8 in patients with atopic dermatitis. Additionally, patients with atopic dermatitis had higher serum levels of type 2 immune response markers such as eotaxin-2, IL-5, IL-3, and TARC. Circulating eosinophils in patients with atopic dermatitis show a distinct phenotypic profile, suggesting a role in atopic dermatitis pathophysiology and potential involvement in differential treatment responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicEosinophilsAntigens, CDHLA-DR AntigensReceptors, ImmunologicLectinsAntigens, Differentiation, B-LymphocyteHumansFemaleMaleAdultChildPhenotypeAdolescentYoung AdultProspective StudiesMiddle AgedChild, PreschoolImmunophenotypingReceptors, Prostaglandin

Stichwörter der Autor:innen

CRTH2HLA-DRSiglec-8atopic dermatitiseosinophils

Substanzen

Antigens, CDHLA-DR AntigensReceptors, ImmunologicSIGLEC8 protein, humanprostaglandin D2 receptorLectinsAntigens, Differentiation, B-LymphocyteReceptors, Prostaglandin

Autor:innen und Institutionen

  • CHU Lille, Univ. Lille, Service de Dermatologie, Rue Michel Polonowski, F-59000 Lille, France.
  • U1286-Infinite-Institute for Translational Research in Inflammation, Univ. Lille, Inserm, CHU Lille, 1, Place Verdun, F-59000 Lille, France.
  • Centre de Référence National des Syndromes Hyperéosinophiliques (CEREO), Rue Michel Polonowki, F-59000 Lille, France.
  • Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine and Public Health, University of Wisconsin, 5158 Medical Foundation Centennial Building, 1685 Highland Ave, Madison,…
  • Institut d'Immunologie, CHU Lille, Boulevard du Pr Jules Leclercq, F-59000 Lille, France.
  • Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), CHU Lille, Rue Michel Polonowski, F-59000 Lille, France.

ORCID-Profile: Frédéric Dezoteux, Pierre Marcant, Arnaud Dendooven, Stéphane Esnault, Guillaume Lefèvre, Delphine Staumont-Sallé

Förderung

  • French Society of Dermatology

Zitieren

APA

Dezoteux, F., Marcant, P., Dendooven, A., Delaunay, É., Esnault, S., Trauet, J., Lefèvre, G., & Staumont-Sallé, D. (2025). Enhanced Siglec-8 and HLA-DR and reduced CRTH2 surface expression highlight a distinct phenotypic signature of circulating eosinophils in atopic dermatitis. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiaf023

Vancouver

Dezoteux F, Marcant P, Dendooven A, Delaunay É, Esnault S, Trauet J, et al. Enhanced Siglec-8 and HLA-DR and reduced CRTH2 surface expression highlight a distinct phenotypic signature of circulating eosinophils in atopic dermatitis. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiaf023

BibTeX
@article{Dezoteux2025,
  author = {Dezoteux, Frédéric and Marcant, Pierre and Dendooven, Arnaud and Delaunay, Émeline and Esnault, Stéphane and Trauet, Jacques and Lefèvre, Guillaume and Staumont-Sallé, Delphine},
  title = {Enhanced Siglec-8 and HLA-DR and reduced CRTH2 surface expression highlight a distinct phenotypic signature of circulating eosinophils in atopic dermatitis},
  journal = {Journal of Leukocyte Biology},
  year = {2025},
  doi = {10.1093/jleuko/qiaf023}
}
Kostenlos starten →